Nexgel Inc risk profile
41 Elevated one input has moved against it
Measured 1 September 2026 from NXGL's filed statements. Recomputed nightly.
41 (Elevated), driven by Cash conversion at 100, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 84 | Acute | Volatile | One-year price volatility — 108.9% |
| Operating pressure | 4 | Contained | Worsening | Costs outgrowing revenue — -10.8 percentage points |
| Cash conversion | 100 | Acute | Stable | Capital spending against operating cash — -0.05x |
| Leverage and coverage | 90 | Acute | Worsening | Net debt to EBITDA |
| Competitive position | 20 | Normal | Stable | R&D-intensity gap against peers — -145.3 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.